Over the last 12 months, two agilon health, inc. insiders picked up shares with their own money, about $351,000 in total, and none of them sold.
The largest purchase came from Shaker Benjamin (Executive Officer), about $300,000.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 178 funds reported holding AGL at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Shaker Benjamin | Executive Officer | Buy | 500,000 | $0.60 | $300K | SEC |
| Jan 30, 2026 | Wulf John William | Director | Buy | 81,000 | $0.63 | $51K | SEC |
| Apr 3, 2025 | Schwaneke Jeffrey A. | CFO | Buy | 22,300 | $11.22 | $250K | SEC |
| Dec 13, 2024 | McLoughlin Karen | Director | Buy | 25,000 | $2.20 | $55K | SEC |
| Dec 13, 2024 | Battaglia Silvana | Director | Buy | 25,062 | $2.01 | $50K | SEC |
| Dec 11, 2024 | MCKENZIE DIANA | Director | Buy | 12,500 | $2.28 | $28K | SEC |
| Dec 11, 2024 | MCKENZIE DIANA | Director | Buy | 7,500 | $2.20 | $16K | SEC |
| Dec 11, 2024 | Wulf John William | Director | Buy | 45,000 | $2.18 | $98K | SEC |
| Sep 16, 2024 | Sell Steven | CEO | Buy | 20,000 | $3.36 | $67K | SEC |
| Nov 30, 2023 | Schwaneke Jeffrey A. | Director | Buy | 22,300 | $11.22 | $250K | SEC |
| Nov 21, 2023 | Sell Steven | CEO | Buy | 44,690 | $11.14 | $498K | SEC |
| Sep 14, 2023 | Shaker Benjamin | Executive Officer | Sell | 18,750 | $18.00 | $338K | SEC |
| Sep 14, 2023 | Shaker Benjamin | Executive Officer | Sell | 18,750 | $18.05 | $338K | SEC |
| Sep 13, 2023 | Gertsch Timothy | Executive Officer | Sell | 8,750 | $18.61 | $163K | SEC |
| Sep 13, 2023 | Gertsch Timothy | Executive Officer | Sell | 17,500 | $18.62 | $326K | SEC |
In the last 12 months agilon health, inc. insiders made open-market purchases worth about $351,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in AGL was filed on 2026-03-03.
178 investment managers reported holding AGL in SEC Form 13F filings for Q2 2026.
No congressional trades in AGL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).